Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19

Pulmonary arterial hypertension (PAH) and novel coronavirus (SARS-CoV-2) disease COVID-19 are characterized by extensive endothelial dysfunction and inflammation leading to vascular remodeling and severe microthrombi and microvascular obliterative disease. It is hypothesized that those patients with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pulm Circ
Asıl Yazarlar: Franco, Veronica, Bradley, Elisa A., Badagliacca, Roberto, Sabanayagam, Aarthi, Rajpal, Saurabh, Lastinger, Lauren T., Daniels, Curt J., Smith, J. Shaun, Benza, Raymond L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2020
Konular:
Leading Edge Science
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7686637/
https://ncbi.nlm.nih.gov/pubmed/33282201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894020970369
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller